Prevalence of non-communicable diseases among people living with HIV at HIV Clinic of Kigali University Teaching hospital (CHUK), a cross-sectional study Authors: Sylvie Turikumwe, Dyna Nyampinga, Alexandre Dukundane, Simeon Turatsinze, Marie Paul Mukantagengwa, Jean Paul Rwabihama, Leopold Bitunguhari Published: 2026 ABSTRACT The introduction of highly active antiretroviral therapy prolonged the life span of PLWHIV and therefore; they live longer and develop chronic diseases, which are associated with ageing related Non-Communicable Diseases. The study aimed to assess the prevalence of non-communicable diseases and associated risk factors among people living with HIV infection at a Tertiary Hospital of Rwanda. A cross-sectional study was conducted to PLWHIV followed at the ambulatory HIV clinic of Kigali University Teaching hospital (CHUK) from August 2019 to Feb 2020, A systematic random sampling approach was used to select participants from the clinic registry. Social-demographic data, psychometric and clinical data were collected using structured questionnaire. Anthropometric and biochemical measurements were performed and results were recorded using Epidata and exported to SPSS for analysis. Logistic regression analysis was used to explore associated risk factors. A total of 222 participants were enrolled from a cohort of 2580 PLWH in care. The overall prevalence of NCDs was 36%. The most common condition was hypertension 22.5%), Diabetes mellitus 9.9%, renal impairment 9.9%, and dyslipidemia 3.2%. Among these NCDs, a high proportion were newly identified cases: 80% for hypertension, 41% for diabetes, and 54% for renal impairment. The most frequent comorbidities were hypertension with renal impairment (35% of comorbid cases), and hypertension with diabetes (30%). Factors independently associated with NCDs included Age above 65years [AOR: 8.3;95%CI:2.3–30, P < 0.001],; physical inactivity [AOR:2.1,95%CI:1.1–3.8, P = 0.013]; adverse drug reaction 50% [AOR:2.2; 95%CI: 1.2–4.1, P = 0.009]. Non- communicable diseases are highly prevalent in PLWHIV, with Hypertension, Diabetes, and renal failure being the most common. A substantial proportion of cases remained. Old age, Physical inactivity, and adverse effect to drugs were significant predictors of NCDs in this population. These findings highlight the need of integrating NCDs screening and management within HIV care services. Introduction The introduction of antiretroviral drugs has prolonged the survival and improved the quality of life among people living with HIV resulting in declining of opportunistic infections and increase in development of chronic disease associated with ageing including cardiovascular diseases, diabetes, chronic kidney disease, chronic lung disease, and some type of neurological complications of HIV and cancers1,2. However, this transition has created dual epidemiological burden of communicable disease (HIV) and NCDs among PLWIV posing new health challenges to healthcare system, mainly in limited-resources settings3,4. Non-communicable diseases remained a great cause of morbidity in PLWHIV, both HIV and NCDs require team approach and health systems that can deliver both effective acute and chronic care and that can support good adherence to treatment and monitor drug effects5,6. Despite this need, many healthcare systems in Sub-Saharan Africa, including Rwanda, are mainly structured around vertical HIV care with limited or no NCDs prevention, screening, or management6. Non-communicable diseases and HIV are major concerns of the public health system in low- and middle-income countries especially in Sub-Saharan Africa7. Recent studies show an increasing burden of non-communicable diseases (NCDs) among people living with HIV (PLWHIV). In Nigeria, the prevalence of hypertension among PLWHIV is estimated at 24.9%, with only about 24.4% achieving blood pressure control8. A systematic review of 188 studies conducted in 21 sub-Saharan African countries reported a pooled hypertension prevalence of 20.1% and a diabetes prevalence of 5.4% among PLWHIV5. While these studies show the regional burden, there is limited Rwanda specific evidence describing the magnitude and pattern of NCDs among PLWHIV. In Rwanda, the 2019–2020 Demographic and Health Survey estimated HIV prevalence among adults aged 15–49 years at 2.7%, with higher rates observed in urban areas 3.7% among women and 3.8% in Kigali City compared to 2.2–2.8% in other provinces9. Rwanda’s Health Management Information System (HMIS) data indicated that Non-Communicable Diseases (NCDs) were among the top eight causes of morbidity in district hospitals. Specifically, NCDs accounted for 22% of inpatient admissions and 51% of outpatient consultations at district hospitals10. However, these data are from the general population and might not reflect the burden of NCDs among PLWHIV, who may have unique risk profiles due to chronic HIV infection and long-term antiretroviral therapy. Although comprehensive HIV care should include integrating interventions like neurocognitive assessment, nutrition assessment with dietary counselling and support, smoking cessation, promoting exercise, monitoring blood pressure, blood sugar and cholesterol, these services are not consistently implemented or evaluated within most HIV clinics settings include Rwanda5,6,11. This gap in evidence limits the ability of policymakers and clinicians to design targeted interventions for prevention and management of NCDs in PLWHIV in Rwanda. Therefore, this study aims to address this gap by testing the hypothesis that NCDs are highly prevalent among PLWHIV attending Kigali University Teaching Hospital (CHUK) and are associated with identifiable demographic, behavioral, and clinical risk factors. Specifically, the objectives are:1 to determine the prevalence of NCDs among PLWHIV at CHUK, and2 to identify factors associated with the occurrence of NCDs in this population. Methods Study design and study settings This was a cross-sectional study conducted at Kigali University Teaching Hospital (CHUK) from August 2019 to Feb 2020. CHUK is a tertiary and teaching hospital with 519 beds, serving more than 6,200,000 million of people, and 16,747 inpatients per year from countrywide, HIV care and treatment follow a DSDM Model. The study was conducted in the ambulatory HIV clinic, which provides follow-up care to a large cohort of people living with HIV (PLWHIV). Study population and eligibility criteria This study enrolled adult people living with HIV followed at CHUK. Adults (≥ 15 years of age), HIV positive patients aware of their status and on ART, willing to participate in the study by signing a consent form. People who refused to consent, vulnerable groups of people like prisoners, pregnant women and people with disability were excluded due to ethical and clinical considerations requiring specialized care pathways and approvals beyond the scope of this study. Sample size determination Using the Cochran formula, the required sample size was estimated at 200 participants based on a 95% confidence level, a 5% margin of error, and an assumed prevalence of 16.8% in the general population12. The sample size was calculated as follows: \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:n=(1.96{)}^{2}\times\:0.168\times\:(1-0.168)/(0.05{)}^{2}=200$$\end{document}. After adjusting for a 10% non-response rate using the formula \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:{n}^{*}=n/(1-0.10)$$\end{document}, the final sample size was increased to 222 participants. Sampling procedure A systematic random sampling method was used. Based on the estimated clinic population (N = 2,582) and the required sample size (n = 222), a sampling interval (k ≈ 10) was calculated. Random numbers were generated using an Excel random number table. These numbers were distributed to patients attending the clinic during their scheduled appointments after excluding non-eligible participants. Every 10th participant was systematically selected and recruited into the study. This approach ensured representativeness while maintaining feasibility in the clinic setting. Participant recruitment and data collection After receiving the research approval letter, all HIV patients meeting the inclusion criteria were consecutively screened and recruited according to the sampling schedule. Written informed consent was obtained prior to enrollment. Data were collected using a pre-established and pre-tested data collection form. Each participant was interviewed and assigned a unique identification code. Data collection involved face-to-face interviews, review of medical records, and extraction of laboratory data from the OpenMRS system and CHUK laboratory database. Data collectors (trained nurses and research assistants) received standardized training on study procedures to ensure consistency and reduce measurement variability. Measures and variables Sociodemographic variables included age, sex, residence, education level, occupation, marital status, smoking and alcohol consumption. Clinical variables included duration of HIV, viral load and CD4 count, ART regimen used and side effect, and concomitant drug use. Anthropometric measurements included height and weight for calculation of BMI. Anthropometric measures were weight and height for calculation of BMI. Measurements were performed by trained nurses and using standardized equipment in the triage room. Blood pressure (BP) was measured using a calibrated BP machine following standard procedures: participants were seated and rested for at least 5 min, and measurements were taken on both arms. Two readings were obtained at 15-minute intervals, and the average value was recorded. BP was expressed in millimeters of mercury (mmHg)13. In this study the participants were followed up for 6 months, the BP measurements were taken every month and the average of findings from the last three measurements were considered. Laboratory investigation measurement included fasting blood glucose, glycated hemoglobin (HbA1c), lipid profile, and renal function tests. Blood samples were taken by trained laboratory technicians and analyzed at CHUK laboratory. Operational definitions (based on WHO and international guidelines) were as follows: Hypertension was diagnosed if systolic BP was ≥ 140 mmHg and/or diastolic BP ≥ 90 mmHg on two measurements13,14. Diabetes mellitus was diagnosed when fasting blood sugar was above 126 mg/dl or Random blood glucose above 200 mg/dl, or glycated hemoglobin above 6, 5 . Dyslipidemia when total cholesterol was above 6.2mmol/l with high LDL-C above 4.1mmol/l and triglyceride above 2.2mmol/l. Renal Impairment when estimated glomerular filtration rate (eGFR)calculated using the Cockcroft–Gault formula were below 90 mL/min/1.73 m²15. Quality control and bias Potential sources of bias were considered and put mitigation strategies in place. Selection bias was minimized by systematic random sampling. Measurement bias was reduced through the use of standardized tools, trained personnel, and validated diagnostic criteria. However, recall bias may have occurred for self-reported behavioral variables such as smoking and alcohol use. Data quality was ensured through pre-testing of tools, daily supervision, and double data entry verification. Statistical analysis Data from data collection form were entered in software by using Epidata 3.1 then exported to SPSS version 25 for analysis. Quantitative data were presented using tables in frequencies and percentages. Pearson Chi-square test was used to determine the association between categorical variables. Fisher’s exact test was used on association with counts less than 5. Binary logistic regression analysis was used to study the associations in the presence or development of different non communicable diseases and their predictors. The statistical significance of associations (significance level) was set at P value < 0.05. Ethical consideration The study adhered to the principles of the Declaration of Helsinki (1964). Ethical approval was obtained from the University of Rwanda Research and Ethics Committee [CMHS/IRB/129/2019], the University Teaching Hospital of Kigali [EC/CHUK/085/2019], and the Institutional Review Board [139/CMHS IRB/2019]. Data collectors external to the participating health facilities were trained in participants’ rights, confidentiality, and research ethics. Written informed consent was obtained from all participants prior to enrollment. Data were collected anonymously, and privacy and confidentiality were strictly maintained throughout and after the study. Participation was voluntary, with no associated benefits, and withdrawal from the study carried no risk. Results Participants characteristics This study enrolled 222 participants over the period of 6 months. Considering the Table 1 below, the participants were predominantly female (60.8%) and the majority were younger and middle aged with mean age of 47 years (SD ± 13.3). The majority of participants were living in urban region, at (90.1%) and had secondary or higher education (75.2%). Lifestyle related risks were assessed, 23% and 9% reported alcohol consumption and were smokers respectively. Physical inactivity was reported at 70.3% of participants. Regarding nutritional status 53.2 had normal BMI, 41.4% were overweight/obese (BMI ≥ 25 kg/m²), and 5.4% were underweight (BMI < 18.5 kg/m²). Table 1Socio-demographic and lifestyle characteristics of study participants (n = 222).VariableFrequency (N)Percentage (%)GenderMale8739.2Female13560.8 Marital status Single4520.3Married10245.9Divorced/Separated94.1Widowed6629.7 Age (Years) mean age = 47 SD 13.3 < 35 years4118.535–65 years16473.8> 65 years177.7 BMI category Underweight125.4Normal11853.2Overweight6428.8Obese2812.6 Education Primary/None5524.8Secondary/University16775.2 Occupation Yes2511.3No19788.7 Residence Rural229.9Urban20090.1 Smoking Yes209.0No20291.0 Alcohol consumption Yes5123.0No17177.0 Physical inactivity Yes15670.3No6629.7 Table 1Socio-demographic and lifestyle characteristics of study participants (n = 222).VariableFrequency (N)Percentage (%)GenderMale8739.2Female13560.8 Marital status Single4520.3Married10245.9Divorced/Separated94.1Widowed6629.7 Age (Years) mean age = 47 SD 13.3 < 35 years4118.535–65 years16473.8> 65 years177.7 BMI category Underweight125.4Normal11853.2Overweight6428.8Obese2812.6 Education Primary/None5524.8Secondary/University16775.2 Occupation Yes2511.3No19788.7 Residence Rural229.9Urban20090.1 Smoking Yes209.0No20291.0 Alcohol consumption Yes5123.0No17177.0 Physical inactivity Yes15670.3No6629.7 Socio-demographic and lifestyle characteristics of study participants (n = 222). HIV clinical information Table 2 summarizes HIV-related clinical characteristics of participants. The majority of participants (63.5%) had been living with HIV on ART for more than 10 years. Most participants were on the first line ART (81.5%), while 17.1% and 1.4% were on the second and third line, respectively. Viral load suppression achieved 92% of participants, and 27.0% of the participants reported ADRs to ART. Table 2HIV Clinical information of study participants (n = 222).VariableFrequency (N)Percentage (%)HIV diagnosis duration≤ 10 years8136.5> 10 years14163.5 ART regimen First line18181.5Second line3817.1Third line31.4 Viral load status Suppressed18592.0Not suppressed168.0 ART adherence yes22099.1No20.9 Adverse drug reaction Yes6027.0No16273.0 Table 2HIV Clinical information of study participants (n = 222).VariableFrequency (N)Percentage (%)HIV diagnosis duration≤ 10 years8136.5> 10 years14163.5 ART regimen First line18181.5Second line3817.1Third line31.4 Viral load status Suppressed18592.0Not suppressed168.0 ART adherence yes22099.1No20.9 Adverse drug reaction Yes6027.0No16273.0 HIV Clinical information of study participants (n = 222). NCDs prevalence among participants The main variable is the prevalence of NCDs in the study population. The overall prevalence of NCD among PLWHIV was 36.0%Among them 57.5% were newly diagnosed. The most prevalent NCD was Hypertension 22.5%, followed by Diabetes Mellitus 9.9%and renal impairment 9.9%. Dyslipidemia was less prevalent 3.7%. Most of NCDs were newly diagnosed 80% of hypertension ,41.9% of diabetes, and 54.5% of renal impairment. Other NCDs include heart disease (1.4%, asthma (0.9%), and thyroid disorders (0.9%) were rare and previously diagnosed (see Table 3). Table 3Prevalence of non-communicable diseases among study participants (N = 222).NCDFrequency (N)Percentage (%)NCD present (Yes)8036.0Newly diagnosed4657.5Previously known3442.5Hypertension5022.5Newly Diagnosed4080.0Previously known1020.0Diabetes229.9Newly Diagnosed941.9Previously known1359.1CKD229.9Newly Diagnosed1254.5Previously known1045.5Asthma (Previously Known)20.9Heart diseases (Previously Known)31.4Thyroid disease (Previously Known)20.9Dyslipidemia (Previously Known)73.2 Table 3Prevalence of non-communicable diseases among study participants (N = 222).NCDFrequency (N)Percentage (%)NCD present (Yes)8036.0Newly diagnosed4657.5Previously known3442.5Hypertension5022.5Newly Diagnosed4080.0Previously known1020.0Diabetes229.9Newly Diagnosed941.9Previously known1359.1CKD229.9Newly Diagnosed1254.5Previously known1045.5Asthma (Previously Known)20.9Heart diseases (Previously Known)31.4Thyroid disease (Previously Known)20.9Dyslipidemia (Previously Known)73.2 Prevalence of non-communicable diseases among study participants (N = 222). Factors associated with NCDs among study participants Table 4 shows that older age was strongly associated with NCDs, Elderly people with age above 65years had a significantly high risk of developing NCD % [AOR: 8.36; 95%CI:2.31–11.52, p = 0.001] compared to those below 35 years old; whereas people aged between 35 and 65 years were 3.73 times more likely to develop NCD compared to people below 35 years old [AOR: 3.73; 95%CI:1.52–941, p = 0.005]. Physical inactivity was also associated with increased risk of non-communicable disease with 48.5% prevalence among inactive participants versus 30.1% among active participants (AOR: 2.17; 95% CI: 1.10–3.82; p = 0.013). Participants with Adverse drug reactions had higher prevalence of NCDs 50% vs. 30% of patients without ADR (AOR:2.26, 95%CI:1,24-4.17, P = 0.009). Table 4Association of non-communicable disease and different predictors (n = 222).PredictorPresence of NCDCOR (95% CI)P-valueaOR (95% CI)P-valueYes N(%)NoN(%)GenderMale28 (32.2)59 (67.8)1.32 (0.75–2.33)0.338Female52 (38.5)83 (61.5)1 Marital status Single7 (15.6)38 (84.4)5.43(2.12–13.89) < 0.001 3.68(0.54–4.75)0.069Married37 (36.3)65 (63.7)1.76(0.94–3.30)0.0791.42(0.71–2.96)0.121Divorced/Separated3 (33.3)6 (67.7)2.00(0.46–8.68)0.3552.34(0.95–3.79)0.287Widowed33 (50.0)33(50.0)1 Residence Rural11 (50.0)11 (50.0)1.35(1.12–3.34) 0.047 1.80(0.72–4.61)0.156Urban69 (34.5)131 (65.5)11 Smoking Yes8 (40.0)12 (60.0)1.63(1.23–2.81) 0.049 1.25(0.41–3.10)0.699No72 (35.6)130 (64.4)11 Alcohol consumption Yes23 (45.1)28 (54.9)2.01(1.91–3.72) 0.041 1.62(0.83–3.19)0.126No57 (33.3)114 (66.7)1 Age < 35 years6 (14.6)35 (85.4)1135–65 years64 (39.0)100 (61.0)1.80(1.21–3.47) < 0.001 3.73(1.52–9.41) 0.005 > 65 years10 (58.8)7 (41.2)4.34(2.87–7.98) 0.004 8.36(2.31–11.52) 0.001 BMI category Underweight2 (16.7)10 (83.3)1Normal41 (34.7)77 (65.3)1.37(0.75–2.38)0.276Overweight24 (37.5)40 (62.5)2.45(0.98–3.05)0.138Obese13 (46.4)15 (53.6)1.72(0.23–2.87)0.096 Education None/Primary25 (45.5)30 (54.5)1.20(1.03–2.73) 0.028 1.74(0.93–3.27)0.095Secondary/University55 (32.9)112 (67.1)1 Occupation Yes7 (28.0)18 (72.0)2.44(0.78-3-96)0.374No73 (37.1)124 (62.9)1 Physical inactivity Yes48 (30.8)108 (69.2)1.98(1.06–4.21) 0.002 2.17(1.10–3.82) 0.013 No32 (48.5)34 (51.5)1 ART regimen First line67 (37.0)114 (63.0)1Second line12 (31.6)26 (68.4)1.34(0.068-2.09)0.814Third line1(33.3)2 (66.7)2.93(0.98–3.92)0.998 ART interruption Yes80 (36.4)140 (63.6)1NoYes0(0.0)2 (100.0)3.14(0.92–5.23)0.286 Viral load status Suppressed69 (37.3)116 (62.7)3.31(2.67–7.66) 0.046 4.18(0.94–11.81)0.064Not suppressed2 (12.5)14 (87.5)11 Adverse drug reaction Yes30 (50.0)30 (50.0)1.78(1.07–3.18) 0.008 2.26 (1.24–4.17) 0.009 No50 (39.9)112 (69.1)1 HIV duration ≤ 10 years28 (34.6)53 (65.4)1.18 (0.67–1.98)0.073> 10 years52 (36.9)89 (63.1)1 Table 4Association of non-communicable disease and different predictors (n = 222).PredictorPresence of NCDCOR (95% CI)P-valueaOR (95% CI)P-valueYes N(%)NoN(%)GenderMale28 (32.2)59 (67.8)1.32 (0.75–2.33)0.338Female52 (38.5)83 (61.5)1 Marital status Single7 (15.6)38 (84.4)5.43(2.12–13.89) < 0.001 3.68(0.54–4.75)0.069Married37 (36.3)65 (63.7)1.76(0.94–3.30)0.0791.42(0.71–2.96)0.121Divorced/Separated3 (33.3)6 (67.7)2.00(0.46–8.68)0.3552.34(0.95–3.79)0.287Widowed33 (50.0)33(50.0)1 Residence Rural11 (50.0)11 (50.0)1.35(1.12–3.34) 0.047 1.80(0.72–4.61)0.156Urban69 (34.5)131 (65.5)11 Smoking Yes8 (40.0)12 (60.0)1.63(1.23–2.81) 0.049 1.25(0.41–3.10)0.699No72 (35.6)130 (64.4)11 Alcohol consumption Yes23 (45.1)28 (54.9)2.01(1.91–3.72) 0.041 1.62(0.83–3.19)0.126No57 (33.3)114 (66.7)1 Age < 35 years6 (14.6)35 (85.4)1135–65 years64 (39.0)100 (61.0)1.80(1.21–3.47) < 0.001 3.73(1.52–9.41) 0.005 > 65 years10 (58.8)7 (41.2)4.34(2.87–7.98) 0.004 8.36(2.31–11.52) 0.001 BMI category Underweight2 (16.7)10 (83.3)1Normal41 (34.7)77 (65.3)1.37(0.75–2.38)0.276Overweight24 (37.5)40 (62.5)2.45(0.98–3.05)0.138Obese13 (46.4)15 (53.6)1.72(0.23–2.87)0.096 Education None/Primary25 (45.5)30 (54.5)1.20(1.03–2.73) 0.028 1.74(0.93–3.27)0.095Secondary/University55 (32.9)112 (67.1)1 Occupation Yes7 (28.0)18 (72.0)2.44(0.78-3-96)0.374No73 (37.1)124 (62.9)1 Physical inactivity Yes48 (30.8)108 (69.2)1.98(1.06–4.21) 0.002 2.17(1.10–3.82) 0.013 No32 (48.5)34 (51.5)1 ART regimen First line67 (37.0)114 (63.0)1Second line12 (31.6)26 (68.4)1.34(0.068-2.09)0.814Third line1(33.3)2 (66.7)2.93(0.98–3.92)0.998 ART interruption Yes80 (36.4)140 (63.6)1NoYes0(0.0)2 (100.0)3.14(0.92–5.23)0.286 Viral load status Suppressed69 (37.3)116 (62.7)3.31(2.67–7.66) 0.046 4.18(0.94–11.81)0.064Not suppressed2 (12.5)14 (87.5)11 Adverse drug reaction Yes30 (50.0)30 (50.0)1.78(1.07–3.18) 0.008 2.26 (1.24–4.17) 0.009 No50 (39.9)112 (69.1)1 HIV duration ≤ 10 years28 (34.6)53 (65.4)1.18 (0.67–1.98)0.073> 10 years52 (36.9)89 (63.1)1 Association of non-communicable disease and different predictors (n = 222). Discussion This research aimed to determine the prevalence and identify the factors associated with NCD among PLWHIV. NCD prevalence in people living in HIV In this study, 222 participants were enrolled, and the overall prevalence of NCD was 36.0% with hypertension (22.5%), diabetes mellitus (9.9%), and renal impairment (9.9%) being the most common conditions. A substantial proportion of cases were newly diagnosed (57.5%), including 80% of hypertension, 41.9% of diabetes, and 54.5% of renal impairment, indicating gaps in routine screening within HIV care services. The prevalence of NCD in the study population was high compared to Southern Ethiopia evidenced by a study on adults living with HIV reported a prevalence of 6.9% for diabetes mellitus, 18.5% for hypertension, and 21.9% for either condition, with 61% of individuals with diabetes were newly diagnosed5,16. In Uganda the prevalence of HTN and Diabetes are reported to be low to Rwanda but higher to Ethiopia at 12.4% and 4,7%, respectively4,17,18. The high number of NCDs being newly diagnosed during studies indicates substantial gaps in early detection and management. The high number of NCDs reported among people living with HIV underscore the need for integrated screening and management within HIV care services5,16,19. Risk factors associated with NCD in study participants The risk factors found to be associated with NCD from this study were advanced age, physical inactivity and adverse drug reactions. Advanced age (> 65 years) was strongly associated with NCDs, which is consistent with findings from studies conducted in South Africa and Zimbabwe, where increasing age (above 45 in South Africa and above 55 in Zimbabwe) were key predictors of hypertension and diabetes4,20. he association between advanced age and noncommunicable diseases can be explained biologically, as aging is associated with cumulative exposure to metabolic risk factors and progressive physiological changes that increase susceptibility to chronic diseases; among people living with HIV, these age-related processes may further accelerate the development of comorbid conditions21. Physical inactivity was associated with increased risk of NCD. This finding aligns with existing evidence from Democratic Republic of Congo (DRC) where low physical exercise was associated with increased risk of NCD22. DRC is in the same region with study settings; there is no big difference between our populations and the baseline characteristics of study participants were similar. Adverse drug reaction was associated with increased odds of NCDs. Which is consistent with a study done in DRC which found that protease inhibitors and stavudine containing antiretroviral therapy were associated with high risk of metabolic syndrome and NCD23. Another study done in Ethiopia found that longer duration on ART was associated with high prevalence of HTN5,16 and in Nigeria where HTN prevalence doubled after two years of starting antiretroviral therapy8. The observed increased odds of non-communicable diseases (NCDs) among participants with adverse drug reactions (ADRs) may reflect the well-documented metabolic effects of long-term antiretroviral therapy (ART); however, this association should be interpreted cautiously, as ADRs may also indicate prolonged ART exposure or a more complex underlying clinical profile rather than representing an independent causal factor24,25. Study limitation This study was a cross-sectional study, hence limiting its ability to establish causal relationships between risk factors and NCDs. Furthermore, some behavior variables like alcohol consumption, physical activity were self-reported and may be subject to recall or social desirability bias. Finally, this study was done in urban tertiary hospitals which may limit generalization of its findings, particularly in primary care settings and rural areas. Study implication Despite some limitations, this study findings shed light on the substantial burden of undiagnosed NCDs among PLWHIV and highlight the need of integrating NCDs routine screening in HIV care programs. Integration of NCD services into HIV care could improve early detection and management, particularly for hypertension, diabetes, and renal disease. Conclusion This study demonstrated a high burden of NCDs among PLWHIV attending CHUK HIV clinic, with hypertension, Diabetes, and renal impairment being most common. More than a half of NCDs in this population was undiagnosed. Advanced age, physical inactivity, and adverse drug reactions were independently associated with NCDs in this population. However, due to the cross-sectional design, causal relationships cannot be established. The limited integration of NCDs in HIV care is contributing to increasing incidence and leads to poor regular control of NCDs in the HIV population attending HIV clinics. Recommendations Based on the study findings these recommendations are proposed:1 Screening NCD’s mainly HTN, Diabetes, and Renal impairment should be systematically integrated into HIV care at all levels of healthcare system2, Development and implement a HIV-NCD integration model3, To address modifiable risk factors like physical inactivity by integrating targeted intervention in HIV care4, Enhance pharmacovigilance to regularly monitor ADRs mainly for PLWHIV stayed on ART for long time5, Further longitudinal, multiple centers studies are needed to improve generalization of findings and understand causal relationship between risk factors and NCDs7, Further study on vulnerable study like prisoner, pregnant women and people with disability are needed to explore possible different NCD risk profiles in this sub-population.